In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
A potential malaria vaccine has shown promising results in early stage clinical trials, researchers announced this week.
Bloomberg reports on efforts to develop the first vaccine for dengue fever.
The Chinese Center for Disease Control and Prevention and Aeras have signed a memorandum of understanding to advance research and development for new vaccines to prevent tuberculosis.
The University of Washington has received $9.6 million grant from the Department of Defense to continue work developing a diagnostic test for infectious diseases in low-resource settings.
The US Food and Drug Administration (FDA) tentatively approved India-based pharmaceutical company Strides Arcolab’s HIV drug.
Legislation recently introduced in the US House of Representatives would amend a five-year exclusivity provision for new combination drugs approved by the FDA.
Think Africa Press examines how a new treatment for visceral leishmaniasis, under development by the Drugs for Neglected Diseases initiative, could help patients in Kenya.